Mild encephalitis/encephalopathy with reversible splenial lesion (MERS) in twin sisters with two CD36 frameshift

Antonio Gatto1, Paolo Mariotti2, Domenico Umberto De Rose3

  • 1Institute of Pediatrics, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo Agostino Gemelli 8, 00168, Rome, Italy. antonio.gatto@policlinicogemelli.it.

Insights

Mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) is a rare condition. This study identified CD36 gene mutations in twin sisters with MERS, suggesting a genetic link to this neurological syndrome.

Area of Science:

  • Neurology
  • Genetics
  • Pediatrics

Background:

  • Mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) is a clinical-radiological syndrome characterized by a good prognosis, primarily affecting children and young adults.
  • MERS is often associated with viral infections, but the underlying genetic predisposition is not well understood.

Purpose of the Study:

  • To investigate the potential genetic factors contributing to MERS in pediatric patients.
  • To identify specific gene mutations associated with the development of MERS in affected individuals.

Main Methods:

  • Case study of twin sisters diagnosed with MERS.
  • Next-generation exome sequencing to identify genetic variations.
  • Sanger sequencing for confirmation of identified mutations.

Main Results:

  • Two different frameshift mutations in the CD36 gene (NM_000072) were identified in both twin sisters.
  • These mutations were confirmed through Sanger sequencing.
  • The study proposes an association between CD36 mutations and MERS, potentially influencing inflammation and callosal alterations during viral infections.

Conclusions:

  • This study reports a novel association between CD36 gene mutations and Mild encephalitis/encephalopathy with a reversible splenial lesion (MERS).
  • The findings suggest that CD36 mutations may play a role in the pathogenesis of MERS, particularly in the context of viral infections and associated inflammation.
  • Further research is warranted to elucidate the precise mechanisms linking CD36 to MERS and its neurological manifestations.

Related Concept Videos